Catalyst Wire Dossier Catalyst Wire Dossier

ZITUVIMET XR

sitagliptin and metformin hydrochloride · Zydus Pharmaceuticals USA Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZITUVIMET XR, covering 2024-07-18 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: ZITUVIMET XR — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

See pricing